See more : CG Oncology, Inc. Common stock (CGON) Income Statement Analysis – Financial Results
Complete financial analysis of CONMED Corporation (CNMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CONMED Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Houghton Mifflin Harcourt Company (HMHC) Income Statement Analysis – Financial Results
- Shanghai HIUV New Materials Co.,Ltd (688680.SS) Income Statement Analysis – Financial Results
- NIKE, Inc. (NKE) Income Statement Analysis – Financial Results
- Verbund AG (OEWA.DE) Income Statement Analysis – Financial Results
- Sungshin Cement Co., Ltd (004980.KS) Income Statement Analysis – Financial Results
CONMED Corporation (CNMD)
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.24B | 1.05B | 1.01B | 862.46M | 955.10M | 859.63M | 796.39M | 763.52M | 719.17M | 734.47M | 756.76M | 767.14M | 725.08M | 713.72M | 694.74M | 742.18M | 694.29M | 646.81M | 617.31M | 558.39M | 497.13M | 453.06M | 428.72M | 392.23M | 372.60M | 336.40M | 138.30M | 125.60M | 99.60M | 71.10M | 53.60M | 42.60M | 38.50M | 31.40M | 19.90M | 14.20M | 12.50M | 10.50M |
| Cost of Revenue | 568.50M | 474.23M | 442.60M | 402.16M | 430.38M | 390.52M | 365.35M | 355.19M | 337.47M | 336.00M | 350.29M | 361.30M | 350.14M | 348.34M | 357.41M | 359.80M | 345.16M | 333.97M | 304.28M | 271.50M | 237.43M | 215.89M | 204.37M | 158.74M | 152.80M | 146.00M | 67.20M | 59.00M | 47.40M | 34.90M | 26.90M | 20.30M | 18.40M | 15.30M | 11.70M | 7.50M | 6.40M | 5.50M |
| Gross Profit | 676.25M | 571.25M | 568.04M | 460.30M | 524.72M | 469.11M | 431.04M | 408.33M | 381.70M | 398.47M | 406.47M | 405.84M | 374.93M | 365.38M | 337.33M | 382.38M | 349.13M | 312.85M | 313.02M | 286.89M | 259.70M | 237.17M | 224.35M | 233.49M | 219.80M | 190.40M | 71.10M | 66.60M | 52.20M | 36.20M | 26.70M | 22.30M | 20.10M | 16.10M | 8.20M | 6.70M | 6.10M | 5.00M |
| Gross Profit Ratio | 54.33% | 54.64% | 56.21% | 53.37% | 54.94% | 54.57% | 54.12% | 53.48% | 53.08% | 54.25% | 53.71% | 52.90% | 51.71% | 51.19% | 48.56% | 51.52% | 50.29% | 48.37% | 50.71% | 51.38% | 52.24% | 52.35% | 52.33% | 59.53% | 58.99% | 56.60% | 51.41% | 53.03% | 52.41% | 50.91% | 49.81% | 52.35% | 52.21% | 51.27% | 41.21% | 47.18% | 48.80% | 47.62% |
| Research & Development | 52.60M | 47.15M | 43.57M | 40.47M | 45.46M | 42.19M | 32.31M | 32.25M | 27.44M | 27.78M | 25.83M | 28.21M | 28.65M | 29.65M | 31.84M | 33.11M | 30.40M | 30.72M | 25.47M | 20.21M | 17.31M | 16.09M | 14.83M | 14.87M | 12.10M | 12.00M | 3.00M | 3.00M | 2.80M | 2.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 400.14M | 355.62M | 351.80M | 338.40M | 303.09M | 293.94M | 310.73M | 302.47M | 277.71M | 276.46M | 266.31M | 272.44M | 240.54M | 234.83M | 216.69M | 183.18M | 157.45M | 141.74M | 140.56M | 124.67M | 107.20M | 93.60M | 35.30M | 31.60M | 25.60M | 21.00M | 25.30M | 14.30M | 11.90M | 10.10M | 6.90M | 5.00M | 3.90M | 3.30M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 504.71M | 454.04M | 414.75M | 373.82M | 400.14M | 355.62M | 351.80M | 338.40M | 303.09M | 293.94M | 310.73M | 302.47M | 277.71M | 276.46M | 266.31M | 272.44M | 240.54M | 234.83M | 216.69M | 183.18M | 157.45M | 141.74M | 140.56M | 124.67M | 107.20M | 93.60M | 35.30M | 31.60M | 25.60M | 21.00M | 25.30M | 14.30M | 11.90M | 10.10M | 6.90M | 5.00M | 3.90M | 3.30M |
| Other Expenses | 0.00 | -112.01M | -1.13M | -355.00K | -5.19M | 0.00 | 0.00 | -2.94M | 0.00 | 7.32M | 8.75M | 7.20M | 0.00 | 2.18M | 10.92M | 1.58M | -4.63M | 51.90M | 7.12M | 20.34M | -2.92M | 0.00 | 0.00 | 29.49M | 25.70M | 23.60M | 7.00M | 6.40M | 0.00 | 3.90M | 3.30M | 2.20M | 2.10M | 1.60M | 1.00M | 600.00K | 400.00K | 300.00K |
| Operating Expenses | 555.64M | 501.19M | 458.32M | 414.29M | 445.60M | 397.81M | 384.11M | 370.65M | 330.53M | 345.68M | 349.96M | 340.63M | 306.36M | 308.29M | 309.06M | 307.12M | 266.31M | 317.45M | 249.27M | 223.73M | 171.84M | 157.82M | 155.39M | 169.03M | 145.00M | 129.20M | 45.30M | 41.00M | 33.40M | 27.30M | 28.60M | 16.50M | 14.00M | 11.70M | 7.90M | 5.60M | 4.30M | 3.60M |
| Cost & Expenses | 1.12B | 975.42M | 900.92M | 816.45M | 875.98M | 788.33M | 749.46M | 725.84M | 667.99M | 681.68M | 700.25M | 701.93M | 656.50M | 656.63M | 666.47M | 666.92M | 611.48M | 651.42M | 553.56M | 495.23M | 409.28M | 373.71M | 359.76M | 327.77M | 297.80M | 275.20M | 112.50M | 100.00M | 80.80M | 62.20M | 55.50M | 36.80M | 32.40M | 27.00M | 19.60M | 13.10M | 10.70M | 9.10M |
| Interest Income | 0.00 | 28.91M | 35.49M | 44.05M | 42.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 39.78M | 28.91M | 35.49M | 44.05M | 42.70M | 20.65M | 18.20M | 15.36M | 6.03M | 6.11M | 5.61M | 5.73M | 6.68M | 7.11M | 7.09M | 10.37M | 16.23M | 19.12M | 15.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 51.40M | 49.76M | 49.79M | 52.24M | 50.99M | 61.80M | 58.55M | 55.31M | 43.88M | 45.73M | 47.87M | 46.62M | 42.69M | 41.81M | 41.28M | 32.34M | 31.53M | 29.85M | 30.79M | 26.87M | 24.85M | 22.37M | 30.15M | 29.49M | 25.70M | 23.60M | 7.00M | 6.40M | 5.00M | 3.90M | 3.30M | 2.20M | 2.10M | 1.60M | 1.00M | 600.00K | 400.00K | 300.00K |
| EBITDA | 192.48M | 7.80M | 158.38M | 113.58M | 124.91M | 133.11M | 105.48M | 90.04M | 95.05M | 98.52M | 104.11M | 111.83M | 47.06M | 94.58M | 66.52M | 111.97M | 112.53M | 25.25M | 94.53M | 89.20M | 112.71M | 101.72M | 99.11M | 93.95M | 100.50M | 84.80M | 32.80M | 32.00M | 23.80M | 12.80M | 1.40M | 8.00M | 8.20M | 6.00M | 1.30M | 1.70M | 2.20M | 1.70M |
| EBITDA Ratio | 15.46% | -4.01% | 10.74% | 5.29% | 7.74% | 8.29% | 5.89% | 11.79% | 13.22% | 13.41% | 13.79% | 14.58% | 15.34% | 13.86% | 10.01% | 14.50% | 16.07% | 12.03% | 16.47% | 19.91% | 25.30% | 22.45% | 23.12% | 23.95% | 26.97% | 25.21% | 50.04% | 25.48% | 23.90% | 18.00% | 2.99% | 18.08% | 20.52% | 19.11% | 6.03% | 10.56% | 16.80% | 16.19% |
| Operating Income | 130.79M | 70.05M | 37.85M | -26.97M | 1.60M | 71.31M | 46.94M | 37.68M | 51.18M | 52.79M | 56.51M | 65.21M | 8.27M | 57.09M | 28.27M | 75.26M | 80.99M | -4.60M | 63.75M | 63.16M | 79.96M | 79.35M | 68.96M | 64.46M | 74.80M | 61.20M | 25.80M | 25.60M | 18.80M | 8.90M | -1.90M | 5.80M | 6.10M | 4.40M | 300.00K | 1.10M | 1.80M | 1.40M |
| Operating Income Ratio | 10.51% | 6.70% | 3.74% | -3.13% | 0.17% | 8.29% | 5.89% | 4.93% | 7.12% | 7.19% | 7.47% | 8.50% | 1.14% | 8.00% | 4.07% | 10.14% | 11.67% | -0.71% | 10.33% | 11.31% | 16.08% | 17.51% | 16.08% | 16.44% | 20.08% | 18.19% | 18.66% | 20.38% | 18.88% | 12.52% | -3.54% | 13.62% | 15.84% | 14.01% | 1.51% | 7.75% | 14.40% | 13.33% |
| Total Other Income/Expenses | -49.96M | -140.92M | -36.61M | -44.41M | -47.89M | -20.65M | -18.20M | -18.30M | -6.03M | -6.11M | -5.88M | -5.73M | -59.40M | -11.44M | -10.11M | -6.00M | -13.43M | -19.80M | -15.58M | -13.60M | -26.95M | -25.99M | -30.82M | -34.29M | -32.30M | -30.90M | -36.50M | -100.00K | -2.00M | -600.00K | -200.00K | 300.00K | -200.00K | -700.00K | -100.00K | 100.00K | 0.00 | -200.00K |
| Income Before Tax | 80.83M | -70.86M | 73.11M | 1.60M | 31.23M | 50.65M | 28.73M | 19.38M | 45.14M | 46.68M | 50.63M | 59.48M | -2.31M | 45.66M | 18.16M | 69.26M | 64.76M | -24.40M | 48.17M | 49.56M | 53.01M | 54.84M | 38.13M | 30.18M | 42.50M | 30.30M | -10.70M | 25.50M | 16.80M | 8.30M | -2.10M | 6.10M | 5.90M | 3.70M | 200.00K | 1.20M | 1.80M | 1.20M |
| Income Before Tax Ratio | 6.49% | -6.78% | 7.23% | 0.19% | 3.27% | 5.89% | 3.61% | 2.54% | 6.28% | 6.35% | 6.69% | 7.75% | -0.32% | 6.40% | 2.61% | 9.33% | 9.33% | -3.77% | 7.80% | 8.88% | 10.66% | 12.10% | 8.89% | 7.69% | 11.41% | 9.01% | -7.74% | 20.30% | 16.87% | 11.67% | -3.92% | 14.32% | 15.32% | 11.78% | 1.01% | 8.45% | 14.40% | 11.43% |
| Income Tax Expense | 16.37M | 9.72M | 10.56M | -7.91M | 2.61M | 9.80M | -26.76M | 4.71M | 14.65M | 14.48M | 14.69M | 19.00M | -3.06M | 15.31M | 6.02M | 24.70M | 23.30M | -11.89M | 16.18M | 16.10M | 20.93M | 19.74M | 13.73M | 10.86M | 15.30M | 10.90M | -3.60M | 9.20M | 5.90M | 2.90M | -700.00K | 2.00M | 2.00M | 1.30M | 100.00K | 400.00K | 700.00K | 500.00K |
| Net Income | 64.46M | -80.58M | 62.54M | 9.52M | 28.62M | 40.85M | 55.49M | 14.66M | 30.50M | 32.19M | 35.94M | 40.48M | 752.00K | 30.35M | 12.14M | 44.56M | 41.46M | -12.51M | 31.99M | 33.47M | 32.08M | 34.15M | 24.41M | 19.31M | 27.20M | 17.80M | -7.10M | 16.30M | 10.90M | 5.40M | -1.40M | 4.10M | 3.90M | 2.40M | -300.00K | 800.00K | 1.10M | 700.00K |
| Net Income Ratio | 5.18% | -7.71% | 6.19% | 1.10% | 3.00% | 4.75% | 6.97% | 1.92% | 4.24% | 4.38% | 4.75% | 5.28% | 0.10% | 4.25% | 1.75% | 6.00% | 5.97% | -1.93% | 5.18% | 5.99% | 6.45% | 7.54% | 5.69% | 4.92% | 7.30% | 5.29% | -5.13% | 12.98% | 10.94% | 7.59% | -2.61% | 9.62% | 10.13% | 7.64% | -1.51% | 5.63% | 8.80% | 6.67% |
| EPS | 2.10 | -2.68 | 2.14 | 0.33 | 1.01 | 1.45 | 1.99 | 0.53 | 1.10 | 1.17 | 1.30 | 1.43 | 0.03 | 1.06 | 0.42 | 1.55 | 1.46 | -0.45 | 1.09 | 1.13 | 1.11 | 1.25 | 1.02 | 0.84 | 1.19 | 0.79 | -0.31 | 0.77 | 0.64 | 0.40 | -0.11 | 0.28 | 0.31 | 0.25 | -0.03 | 0.08 | 0.14 | 0.10 |
| EPS Diluted | 2.04 | -2.68 | 1.94 | 0.32 | 0.97 | 1.41 | 1.97 | 0.52 | 1.09 | 1.16 | 1.28 | 1.41 | 0.03 | 1.05 | 0.42 | 1.52 | 1.43 | -0.45 | 1.08 | 1.11 | 1.10 | 1.23 | 1.00 | 0.83 | 1.17 | 0.77 | -0.31 | 0.75 | 0.63 | 0.37 | -0.11 | 0.28 | 0.31 | 0.25 | -0.03 | 0.08 | 0.14 | 0.10 |
| Weighted Avg Shares Out | 30.67M | 30.04M | 29.16M | 28.58M | 28.33M | 28.12M | 27.94M | 27.80M | 27.65M | 27.40M | 27.72M | 28.30M | 28.25M | 28.72M | 29.07M | 28.80M | 28.39M | 27.79M | 29.35M | 29.62M | 28.90M | 27.32M | 23.93M | 22.99M | 22.91M | 22.63M | 22.65M | 21.07M | 17.04M | 13.49M | 13.12M | 14.64M | 12.71M | 9.72M | 11.24M | 10.00M | 7.85M | 7.00M |
| Weighted Avg Shares Out (Dil) | 31.55M | 30.04M | 32.22M | 29.46M | 29.50M | 28.89M | 28.17M | 27.96M | 27.86M | 27.77M | 28.11M | 28.65M | 28.63M | 28.91M | 29.14M | 29.23M | 28.99M | 27.79M | 29.62M | 30.15M | 29.17M | 27.77M | 24.41M | 23.27M | 23.17M | 23.02M | 22.65M | 21.82M | 17.42M | 14.46M | 13.12M | 14.64M | 12.71M | 9.72M | 11.24M | 10.00M | 7.85M | 7.00M |
CONMED Corporation to Announce Third Quarter 2023 Financial Results on October 25, 2023
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2023 after the market close on Wednesday, October 25, 2023. The Company's management will host a conference call at 4:30 p.m. ET...
CNMD vs. ALGN: Which Stock Is the Better Value Option?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Conmed (CNMD) and Align Technology (ALGN). But which of these two stocks is more attractive to value investors?
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the CL King 21st Annual Best Ideas Conference at 10:15 a.m. ET on...
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 2:15 p.m. ET on Thursday, September 7, 2023....
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
CONMED Corporation Announces Quarterly Cash Dividend
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2023, to all shareholders of record as of September 15, 2023. About CONMED...
CONMED (CNMD) Beats on Q2 Earnings, Ups '23 EPS View
CONMED's (CNMD) adjusted second-quarter earnings and sales recover from the disruption in the last two quarters due to implementation of a new warehouse management system.
CONMED Corporation (CNMD) Q2 2023 Earnings Call Transcript
CONMED Corporation (NYSE:CNMD ) Q2 2023 Earnings Conference Call July 26, 2023 4:30 PM ET Company Participants Curt Hartman - Chairman, President, and CEO Todd Garner - EVP and CFO Conference Call Participants Robert Marcus - JPMorgan Rick Wise -...
Conmed (CNMD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Source: https://incomestatements.info
Category: Stock Reports